Patents by Inventor Pengcheng Zhou

Pengcheng Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250146000
    Abstract: The present invention relates to small interfering RNA (siRNA) molecules against the SOD1 gene, adeno-associated viral (AAV) vectors encoding siRNA molecules and methods for treating amyotrophic lateral sclerosis (ALS) using the siRNA molecules and AAV vectors.
    Type: Application
    Filed: September 13, 2024
    Publication date: May 8, 2025
    Inventors: Dinah Wen-Yee SAH, Jinzhao Hou, Mathieu E. Nonnenmacher, Pengcheng Zhou, Markus Hossbach, Jochen Deckert
  • Publication number: 20250115917
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of modulatory polynucleotides.
    Type: Application
    Filed: July 17, 2024
    Publication date: April 10, 2025
    Inventors: Jinzhao Hou, Mathieu E. Nonnenmacher, Pengcheng Zhou
  • Publication number: 20240415868
    Abstract: The present invention relates to small interfering RNA (siRNA) molecules against the HTT gene, adeno-associated viral (AAV) vectors encoding siRNA molecules and methods for treating Huntington's Disease (HD) using the siRNA molecules and AAV vectors.
    Type: Application
    Filed: February 29, 2024
    Publication date: December 19, 2024
    Inventors: Dinah Wen-Yee Sah, Jinzhao Hou, Pengcheng Zhou, Xin Wang, Jochen Deckert, Markus Hossbach
  • Patent number: 12123002
    Abstract: The present invention relates to small interfering RNA (siRNA) molecules against the SOD1 gene, adeno-associated viral (AAV) vectors encoding siRNA molecules and methods for treating amyotrophic lateral sclerosis (ALS) using the siRNA molecules and AAV vectors.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: October 22, 2024
    Assignee: Voyager Therapeutics, Inc.
    Inventors: Dinah Wen-Yee Sah, Jinzhao Hou, Mathieu E. Nonnenmacher, Pengcheng Zhou, Markus Hossbach, Jochen Deckert
  • Patent number: 12092819
    Abstract: A head-up display includes a picture generation unit and a first lens. The picture generation unit is configured to output a first light ray and a second light ray. The first light ray is used to output and display a first picture, and the second light ray is used to output and display a second picture. When the first lens is at the first position, the first light ray and the second light ray do not pass through the first lens. When the first lens is at the second position, the first light ray passes through the first lens. The head-up display can implement switching between a single image plane and a plurality of image planes.
    Type: Grant
    Filed: May 1, 2023
    Date of Patent: September 17, 2024
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Pengcheng Zhou, Yuteng Zhang, Hai Yu
  • Publication number: 20240285667
    Abstract: The present disclosure relates to compositions, methods and processes for the formulation and for the administration of a gene therapy agent using parvovirus e.g., adeno-associated virus (AAV) to the CNS, CNS tissues, CNS structures or CNS cells.
    Type: Application
    Filed: November 22, 2023
    Publication date: August 29, 2024
    Inventors: Gregory Robert Stewart, Dinah Wen-Yee Sah, Jinzhao Hou, Adrian Philip Kells, Martin Goulet, Kartik Ramamoorthi, Pengcheng Zhou, Yanqun Shu
  • Patent number: 12071625
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of modulatory polynucleotides.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: August 27, 2024
    Assignee: VOYAGER THERAPEUTICS, INC.
    Inventors: Jinzhao Hou, Mathieu E. Nonnenmacher, Pengcheng Zhou
  • Publication number: 20240226203
    Abstract: The present invention relates to adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating Huntington's Disease (HD).
    Type: Application
    Filed: July 13, 2023
    Publication date: July 11, 2024
    Inventors: Dinah Wen-Yee Sah, Fen Chen, Pengcheng Zhou, Xin Wang, Yanqun Shu, Jinzhao Hou, Jochen Deckert, Markus Hossbach
  • Publication number: 20240131093
    Abstract: The present invention relates to adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating Huntington's Disease (HD).
    Type: Application
    Filed: July 12, 2023
    Publication date: April 25, 2024
    Inventors: Dinah Wen-Yee Sah, Fen Chen, Pengcheng Zhou, Xin Wang, Yanqun Shu, Jinzhao Hou, Jochen Deckert, Markus Hossbach
  • Patent number: 11951121
    Abstract: The present invention relates to small interfering RNA (siRNA) molecules against the HTT gene, adeno-associated viral (AAV) vectors encoding siRNA molecules and methods for treating Huntington's Disease (HD) using the siRNA molecules and AAV vectors.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: April 9, 2024
    Assignee: VOYAGER THERAPEUTICS, INC.
    Inventors: Dinah Wen-Yee Sah, Jinzhao Hou, Pengcheng Zhou, Xin Wang, Jochen Deckert, Markus Hossbach
  • Publication number: 20230399642
    Abstract: The present invention relates to adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating Huntington's Disease (HD).
    Type: Application
    Filed: October 19, 2022
    Publication date: December 14, 2023
    Inventors: Jinzhao Hou, Xin Wang, Dinah Wen-Yee Sah, Pengcheng Zhou
  • Publication number: 20230332156
    Abstract: The present invention relates to small interfering RNA (siRNA) molecules against the SOD1 gene, adeno-associated viral (AAV) vectors encoding siRNA molecules and methods for treating amyotrophic lateral sclerosis (ALS) using the siRNA molecules and AAV vectors.
    Type: Application
    Filed: December 20, 2022
    Publication date: October 19, 2023
    Inventors: Dinah Wen-Yee SAH, Jinzhao HOU, Mathieu E. NONNENMACHER, Pengcheng ZHOU, Markus HOSSBACH, Jochen DECKERT
  • Patent number: 11752181
    Abstract: The present invention relates to adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating Huntington's Disease (HD).
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: September 12, 2023
    Assignee: VOYAGER THERAPEUTICS, INC.
    Inventors: Dinah Wen-Yee Sah, Fen Chen, Pengcheng Zhou, Xin Wang, Yanqun Shu, Jinzhao Hou, Jochen Deckert, Markus Hossbach
  • Publication number: 20230266588
    Abstract: A head-up display includes a picture generation unit and a first lens. The picture generation unit is configured to output a first light ray and a second light ray. The first light ray is used to output and display a first picture, and the second light ray is used to output and display a second picture. When the first lens is at the first position, the first light ray and the second light ray do not pass through the first lens. When the first lens is at the second position, the first light ray passes through the first lens. The head-up display can implement switching between a single image plane and a plurality of image planes.
    Type: Application
    Filed: May 1, 2023
    Publication date: August 24, 2023
    Inventors: Pengcheng Zhou, Yuteng Zhang, Hai Yu
  • Patent number: 11542506
    Abstract: The present invention relates to small interfering RNA (siRNA) molecules against the SOD1 gene, adeno-associated viral (AAV) vectors encoding siRNA molecules and methods for treating amyotrophic lateral sclerosis (ALS) using the siRNA molecules and AAV vectors.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: January 3, 2023
    Assignee: Voyager Therapeutics, Inc.
    Inventors: Dinah Wen-Yee Sah, Jinzhao Hou, Mathieu E. Nonnenmacher, Pengcheng Zhou, Markus Hossbach, Jochen Deckert
  • Publication number: 20220333131
    Abstract: The present invention relates to adeno-associated viral (AAV) particles modulatory polynucleotides encoding at least one siRNA molecules and methods of use thereof.
    Type: Application
    Filed: December 23, 2021
    Publication date: October 20, 2022
    Inventors: Jinzhao Hou, Xin Wang, Pengcheng Zhou, Xiao-Qin Ren, Dinah Wen-Yee Sah
  • Publication number: 20220275367
    Abstract: The present disclosure relates to pharmaceutical compositions of adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating Huntington's Disease (HD).
    Type: Application
    Filed: July 24, 2020
    Publication date: September 1, 2022
    Inventors: Dinah Wen-Yee Sah, Pengcheng Zhou, Jeffrey S. Thompson, Christina Gamba-Vitalo, Jenna Carroll Soper, Steven M. Hersch, Todd Carter, Jacob J. Cardinal, Lori B. Karpes, Bin Liu
  • Publication number: 20220127619
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of modulatory polynucleotides.
    Type: Application
    Filed: October 8, 2021
    Publication date: April 28, 2022
    Inventors: Jinzhao Hou, Mathieu E. Nonnenmacher, Pengcheng Zhou
  • Patent number: 11198873
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of modulatory polynucleotides.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: December 14, 2021
    Assignee: VOYAGER THERAPEUTICS, INC.
    Inventors: Jinzhao Hou, Mathieu E. Nonnenmacher, Pengcheng Zhou
  • Patent number: D1067368
    Type: Grant
    Filed: October 25, 2024
    Date of Patent: March 18, 2025
    Assignee: Huajiapeng Technology (Shenzhen) Co., Ltd.
    Inventor: Pengcheng Zhou